Carrie Krehlik
Human Resources Officer bij Adicet Therapeutics, Inc.
Profiel
Carrie Krehlik is currently the Chief Human Resource Officer & Senior VP at Adicet Therapeutics, Inc. She previously held the same position at Adicet Bio, Inc. from 2017 to 2021.
Prior to that, she was the Chief Human Resources Officer at Global Blood Therapeutics, Inc. from 2021 to 2022.
She also served as Vice President-Human Resources at InterMune, Inc. from 2012 to 2015 and at ZS Pharma, Inc. from 2015 to 2016.
Additionally, she was the Chief Human Resources Officer & Senior VP at resTORbio, Inc. She received an undergraduate degree from Miami University and an MBA from San Francisco State University.
Actieve functies van Carrie Krehlik
| Bedrijven | Functie | Begin |
|---|---|---|
Adicet Therapeutics, Inc.
 Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Human Resources Officer | 01-11-2017 |
Eerdere bekende functies van Carrie Krehlik
| Bedrijven | Functie | Einde |
|---|---|---|
| GLOBAL BLOOD THERAPEUTICS, INC. | Human Resources Officer | 01-12-2022 |
| ADICET BIO, INC. | Human Resources Officer | 01-05-2021 |
| ZS PHARMA INC | Human Resources Officer | 01-06-2016 |
| INTERMUNE INC | Human Resources Officer | 01-03-2015 |
| ADICET BIO, INC. | Human Resources Officer | - |
Opleiding van Carrie Krehlik
| Miami University | Undergraduate Degree |
| San Francisco State University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ADICET BIO, INC. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
resTORbio, Inc.
 resTORbio, Inc. BiotechnologyHealth Technology resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA. | Health Technology |
Adicet Therapeutics, Inc.
Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Health Technology |
ZS Pharma, Inc.
 ZS Pharma, Inc. Pharmaceuticals: MajorHealth Technology ZS Pharma, Inc. engages in the development of development and commercialization of non-absorbed drugs to treat renal, cardiovascular, liver and metabolic diseases. It develops treatment of hyperkalemia. It also focuses on clinical development, novel technology, and clinical trials. The company was founded by Alvaro F. Guillem and Donald Jeffrey Keyser on February 5, 2008 and is headquartered in San Mateo, CA. | Health Technology |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
